Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Hernandez

Showing results (311-320 of 1,241) with videos related to

Pageof 125
Sort By:
American Heart Journal|June 3, 2008
Achieving rapid reperfusion with primary percutaneous coronary intervention remains a challenge: insights from American Heart Association's Get With the Guidelines programRajendra H Mehta, Vincent J Bufalino, Wenqin Pan, et al.
BMJ Open|March 19, 2016
Arrival by ambulance in acute heart failure: insights into the mode of presentation from Acute Studies of Nesiritide in Decompensated Heart Failure (ASCEND-HF)Justin A Ezekowitz, Mohua Podder, Adrian F Hernandez, et al.
Domestic Animal Endocrinology|September 27, 2020
Urinary vanillylmandelic acid:creatinine ratio in dogs with pheochromocytomaE A Soler Arias, R H Trigo, D D Miceli, et al.
Clinical Cardiology|November 8, 2011
Pharmacologic prophylaxis for venous thromboembolism and 30-day outcomes among older patients hospitalized with heart failure: an analysis from the ADHERE national registry linked to Medicare claimsRobb D Kociol, Bradley G Hammill, Adrian F Hernandez, et al.
Peptides|January 1, 1994
Critical residue combinations dictate peptide presentation by MHC class II moleculesJ F Hernandez, F Cretin, S Lombard-Platet, et al.
Transfusion Medicine (Oxford, England)|September 15, 2009
Clinical efficacy and safety of Flebogammadif, a new high-purity human intravenous immunoglobulin, in adult patients with chronic idiopathic thrombocytopenic purpuraA Julia, L Kovaleva, S Loria, et al.
Journal of the American Heart Association|September 13, 2013
Who enrolls in the Medicare Part D prescription drug benefit program? Medication use among patients with heart failureZubin J Eapen, Bradley G Hammill, Soko Setoguchi, et al.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|November 1, 2013
A crisis of the heart: an acute reversible cardiomyopathy bridged to recovery in a patient with Addison's diseaseArun Krishnamoorthy, Robert J Mentz, Kristen A Hyland, et al.
Clinical Cardiology|October 27, 2016
Management of newly treated diabetes in Medicare beneficiaries with and without heart failureLauren B Cooper, Xiaojuan Mi, Robert J Mentz, et al.
JACC. Heart Failure|March 14, 2014
Validated, electronic health record deployable prediction models for assessing patient risk of 30-day rehospitalization and mortality in older heart failure patientsZubin J Eapen, Li Liang, Gregg C Fonarow, et al.
Pageof 125

Showing results (311-320 of 1,241) with videos related to

Sort By:
Pageof 125
American Heart Journal|June 3, 2008
Achieving rapid reperfusion with primary percutaneous coronary intervention remains a challenge: insights from American Heart Association's Get With the Guidelines programRajendra H Mehta, Vincent J Bufalino, Wenqin Pan, et al.
BMJ Open|March 19, 2016
Arrival by ambulance in acute heart failure: insights into the mode of presentation from Acute Studies of Nesiritide in Decompensated Heart Failure (ASCEND-HF)Justin A Ezekowitz, Mohua Podder, Adrian F Hernandez, et al.
Domestic Animal Endocrinology|September 27, 2020
Urinary vanillylmandelic acid:creatinine ratio in dogs with pheochromocytomaE A Soler Arias, R H Trigo, D D Miceli, et al.
Clinical Cardiology|November 8, 2011
Pharmacologic prophylaxis for venous thromboembolism and 30-day outcomes among older patients hospitalized with heart failure: an analysis from the ADHERE national registry linked to Medicare claimsRobb D Kociol, Bradley G Hammill, Adrian F Hernandez, et al.
Peptides|January 1, 1994
Critical residue combinations dictate peptide presentation by MHC class II moleculesJ F Hernandez, F Cretin, S Lombard-Platet, et al.
Transfusion Medicine (Oxford, England)|September 15, 2009
Clinical efficacy and safety of Flebogammadif, a new high-purity human intravenous immunoglobulin, in adult patients with chronic idiopathic thrombocytopenic purpuraA Julia, L Kovaleva, S Loria, et al.
Journal of the American Heart Association|September 13, 2013
Who enrolls in the Medicare Part D prescription drug benefit program? Medication use among patients with heart failureZubin J Eapen, Bradley G Hammill, Soko Setoguchi, et al.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|November 1, 2013
A crisis of the heart: an acute reversible cardiomyopathy bridged to recovery in a patient with Addison's diseaseArun Krishnamoorthy, Robert J Mentz, Kristen A Hyland, et al.
Clinical Cardiology|October 27, 2016
Management of newly treated diabetes in Medicare beneficiaries with and without heart failureLauren B Cooper, Xiaojuan Mi, Robert J Mentz, et al.
JACC. Heart Failure|March 14, 2014
Validated, electronic health record deployable prediction models for assessing patient risk of 30-day rehospitalization and mortality in older heart failure patientsZubin J Eapen, Li Liang, Gregg C Fonarow, et al.
Pageof 125